Email updates

Keep up to date with the latest news and content from BMC Musculoskeletal Disorders and BioMed Central.

Open Access Research article

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study

Yasuhiro Shimojima, Wataru Ishii, Masayuki Matsuda*, Ko-ichi Tazawa and Shu-ichi Ikeda

Author Affiliations

Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan

For all author emails, please log on.

BMC Musculoskeletal Disorders 2012, 13:228  doi:10.1186/1471-2474-13-228

Published: 22 November 2012

Abstract

Background

To investigate whether or not coadministration of tacrolimus (TAC) with prednisolone (PSL) can produce a beneficial effect in the treatment of polymyositis/ dermatomyositis (PM/DM).

Methods

We reviewed medical records of 32 PM/DM patients who had been admitted to our hospital, and abstracted those who had received TAC in addition to oral PSL for treatment. The clinical usefulness of TAC in PM/DM was objectively evaluated focusing upon the manual muscle strength test (MMT) score, serum creatine kinase (CK) and tapering of PSL.

Results

Nine patients with PM and 6 with DM were enrolled in this study. TAC was added because of difficulty in reduction of PSL in 12 patients and recurrence with corticosteroid-induced complications in the remaining 3. Both PM and DM patients showed significant increases in the MMT score and significant decreases in serum CK 1 to 3 months after starting TAC compared with before. Skin symptoms in a clinically amyopathic DM patient also improved 1 month after starting TAC. The daily dosage of PSL could be significantly reduced in both PM and DM after starting TAC compared with before. No serious adverse events ascribable to TAC occurred in any patients.

Conclusion

Additional use of TAC with PSL may safely promote improvement of PM/DM and also accelerate tapering of the latter.

Keywords:
Dermatomyositis; Polymyositis; Tacrolimus